3B Future Health Fund
Investor profile
Venture capital
3B Future Health Fund has backed 6 European tech companies across 6 funding rounds between 2022 and 2024, joining rounds totalling €205M. Most active in Healthtech. Data as of Nov 2026.
Deals
6
distinct rounds
Companies
6
backed
Active span
2022–2024
3 yrs
Total round €
€205M
sum of rounds joined
Deals by year
distinct rounds / year3B Future Health Fund — deals by year — interactive chart.
Data table
| 3B Future Health Fund — deals by year | |
|---|---|
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
Top sectors
by deals3B Future Health Fund — top sectors — interactive chart.
Data table
| 3B Future Health Fund — top sectors | |
|---|---|
| Healthtech | 6 |
Stages
by deals3B Future Health Fund — stages — interactive chart.
Data table
| 3B Future Health Fund — stages | |
|---|---|
| Series B | 4 |
| Series A | 2 |
Countries
by deals3B Future Health Fund — countries — interactive chart.
Data table
| 3B Future Health Fund — countries | |
|---|---|
| Italy | 2 |
| UK | 2 |
| France | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Claris Ventures3
- Schroders Capital3
- 2Invest2
- CDP Venture Capital2
- VI Partners2
- ACE & Company1
- adMare BioInnovations1
- Alef 61
- Astellas Venture Management1
- British Patient Capital1
- Caribou Property Limited1
- Club degli Investitori1
- CRT Pioneer Fund1
- CTI Life Sciences1
- EIC Fund1
- Ersel1
- Evolution Ventures1
- Indaco Venture Partners1
- INKEF Capital1
- Italian Angels for Growth1
- M Ventures1
- Novartis Venture Fund1
- Omnes Capital1
- Panacea Venture1
- Seroba Life Sciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| iOnctura | Switzerland | 1 | €80M |
| Domain Therapeutics | France | 1 | €40M |
| Epsilogen | UK | 1 | €37M |
| Sibylla Biotech | Italy | 1 | €23M |
| Kither Biotech | Italy | 1 | €19M |
| NeoPhore | UK | 1 | €6.8M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| iOnctura | Series B | €80M | 2024-06 |
| Domain Therapeutics | Series A | €40M | 2022-05 |
| Epsilogen | Series B | €37M | 2022-03 |
| Sibylla Biotech | Series A | €23M | 2022-10 |
| Kither Biotech | Series B | €19M | 2022-03 |
| NeoPhore | Series B | €6.8M | 2023-01 |